Literature DB >> 4975365

Biological activity of 5-hydroxymethyluracil and its deoxynucleoside in noninfected and phage-infected Bacillus subtilis.

M Nishihara, N Friedman, H Vasken Aposhian.   

Abstract

(14)C-hydroxymethyldeoxyuridine (dHMU) is specifically incorporated into the deoxyribonucleic acid (DNA) of bacteriophage SP8. Incorporation experiments demonstrate that the initiation of phage SP8 DNA synthesis occurs between 12.5 to 15 min after infection. Incorporation into host DNA does not occur. (14)C-dHMU can be used as an analytical tool for screening conditionally lethal phage mutants containing hydroxymethyluracil in their DNA to select those that are defective in DNA synthesis under restrictive conditions. The pyrimidine, (14)C-hydroxymethyluracil (HMU), is not incorporated into bacterial or phage DNA. Neither HMU nor dHMU can replace thymine as a growth requirement for Bacillus subtilis 168 Ind(-) Thy(-). HMU does not inhibit the utilization of thymine. Although dHMU inhibits deoxythymidine utilization, the inhibition is not competitive.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4975365      PMCID: PMC375747          DOI: 10.1128/JVI.3.2.164-170.1969

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  THE POSSIBLE ROLE OF RECOMBINATION IN THE INFECTION OF COMPETENT BACILLUS SUBTILIS BY BACTERIOPHAGE DEOXYRIBONUCLEIC ACID.

Authors:  S OKUBO; B STRAUSS; M STODOLSKY
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

2.  TRANSFORMABLE THYMINE-REQUIRING MUTANT OF BACILLUS SUBTILS.

Authors:  J L FARMER; F ROTHMAN
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

3.  Thymine deficiency and the normal DNA replication cycle. I.

Authors:  O MAALOE; P C HANAWALT
Journal:  J Mol Biol       Date:  1961-04       Impact factor: 5.469

4.  Effects of 5-halogenated uracils on the growth of Escherichia coli and their incorporation into deoxyribonucleic acids.

Authors:  D B DUNN; J D SMITH
Journal:  Biochem J       Date:  1957-11       Impact factor: 3.857

5.  Incorporation of halogenated pyrimidines into the deoxyribonucleic acids of Bacterium coli and its bacteriophages.

Authors:  D B DUNN; J D SMITH; S ZAMENHOF; G GRIBOFF
Journal:  Nature       Date:  1954-08-14       Impact factor: 49.962

6.  TRANSFORMATION OF BIOCHEMICALLY DEFICIENT STRAINS OF BACILLUS SUBTILIS BY DEOXYRIBONUCLEATE.

Authors:  J Spizizen
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

7.  The deoxycytidylate deaminase found in Bacillus subtilis infected with phage SP8.

Authors:  M Nishihara; A Chrambach; H V Aposhian
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

8.  Deoxythymidylate 5'-nucleotidase. Purification and properties of an enzyme found after infection of Bacillus subtilis with phage SP5C.

Authors:  H V Aposhian; G Y Tremblay
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

9.  A genetic study of temperature-sensitive mutants of the subtilis phage SP82.

Authors:  E Kahan
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

10.  The biosynthesis of a pyrimidine replacing thymine in bacteriophage DNA.

Authors:  D H Roscoe; R G Tucker
Journal:  Biochem Biophys Res Commun       Date:  1964-06-01       Impact factor: 3.575

View more
  4 in total

Review 1.  Bacteriophages of Bacillus subtilis.

Authors:  H E Hemphill; H R Whiteley
Journal:  Bacteriol Rev       Date:  1975-09

2.  Dominance relationships in mixedly infected Bacillus subtilis.

Authors:  S Palefski; H E Hemphill; P E Kolenbrander; H R Whiteley
Journal:  J Virol       Date:  1972-04       Impact factor: 5.103

3.  Biosynthesis of 5-(4'5'-dihydroxypentyl) uracil as a nucleoside triphosphate in bacteriophage SP15-infected Bacillus subtilis.

Authors:  M S Walker; M Mandel
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

4.  Synthesis of the unusual DNA of Bacillus subtilis bacteriophage SP-15.

Authors:  S Neubort; J Marmur
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.